Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%

Clinical trial NCT05659563 · COMPLETED

Trial details

NCT number: NCT05659563
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer, Early-Onset

Start date: 2023-07-20
Primary completion: 2025-01-30
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.